Biotest Aktiengesellschaft (BIO3) - Cash Flow Conversion Efficiency

Latest as of March 2025: -0.114x

Based on the latest financial reports, Biotest Aktiengesellschaft (BIO3) has a cash flow conversion efficiency ratio of -0.114x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-58.10 Million ≈ $-67.93 Million USD) by net assets (€509.60 Million ≈ $595.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Biotest Aktiengesellschaft (BIO3) defensive interval to measure how many days the company can operate on defensive assets alone.

Biotest Aktiengesellschaft - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Biotest Aktiengesellschaft's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Biotest Aktiengesellschaft Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biotest Aktiengesellschaft ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Jiangsu Lianhuan Pharmaceutical Co Ltd SHG:600513	-0.009x
Bintulu Port Holdings Bhd KLSE:5032	0.060x
Raydium Semi-Conductor TW:3592	-0.003x
COMPASS PATHW SP.ADR F:5Y6	0.715x
Nanjing Bestway Intelligent Control Technology Co. Ltd. A SHE:301195	N/A
Chapters Group AG XETRA:CHG	0.040x
Hunan Sokan New Materials Co. Ltd. A SHG:688157	N/A
Fitipower Integrated Technology Inc TW:4961	0.004x

Annual Cash Flow Conversion Efficiency for Biotest Aktiengesellschaft (2002–2024)

The table below shows the annual cash flow conversion efficiency of Biotest Aktiengesellschaft from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see BIO3 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€530.70 Million ≈ $620.44 Million	€60.90 Million ≈ $71.20 Million	0.115x	+2220.40%
2023-12-31	€498.90 Million ≈ $583.27 Million	€-2.70 Million ≈ $-3.16 Million	-0.005x	+95.04%
2022-12-31	€371.10 Million ≈ $433.85 Million	€-40.50 Million ≈ $-47.35 Million	-0.109x	-222.46%
2021-12-31	€380.40 Million ≈ $444.73 Million	€33.90 Million ≈ $39.63 Million	0.089x	+335.65%
2020-12-31	€441.60 Million ≈ $516.28 Million	€-16.70 Million ≈ $-19.52 Million	-0.038x	+46.32%
2019-12-31	€476.90 Million ≈ $557.55 Million	€-33.60 Million ≈ $-39.28 Million	-0.070x	+30.22%
2018-12-31	€495.20 Million ≈ $578.94 Million	€-50.00 Million ≈ $-58.46 Million	-0.101x	-202.38%
2017-12-31	€347.80 Million ≈ $406.61 Million	€34.30 Million ≈ $40.10 Million	0.099x	-46.02%
2016-12-31	€360.70 Million ≈ $421.70 Million	€65.90 Million ≈ $77.04 Million	0.183x	+97.71%
2015-12-31	€412.30 Million ≈ $482.02 Million	€38.10 Million ≈ $44.54 Million	0.092x	+489.25%
2014-12-31	€480.20 Million ≈ $561.40 Million	€-11.40 Million ≈ $-13.33 Million	-0.024x	-51.90%
2013-12-31	€460.70 Million ≈ $538.61 Million	€-7.20 Million ≈ $-8.42 Million	-0.016x	-116.63%
2012-12-31	€369.43 Million ≈ $431.91 Million	€34.73 Million ≈ $40.60 Million	0.094x	-54.92%
2011-12-31	€346.67 Million ≈ $405.29 Million	€72.28 Million ≈ $84.50 Million	0.208x	-17.59%
2010-12-31	€307.61 Million ≈ $359.63 Million	€77.83 Million ≈ $90.99 Million	0.253x	+115.51%
2009-12-31	€269.86 Million ≈ $315.50 Million	€31.68 Million ≈ $37.04 Million	0.117x	-13.75%
2008-12-31	€253.37 Million ≈ $296.22 Million	€34.49 Million ≈ $40.32 Million	0.136x	-5.47%
2007-12-31	€225.76 Million ≈ $263.94 Million	€32.51 Million ≈ $38.01 Million	0.144x	-1.85%
2006-12-31	€179.31 Million ≈ $209.64 Million	€26.31 Million ≈ $30.76 Million	0.147x	-12.46%
2005-12-31	€168.97 Million ≈ $197.55 Million	€28.32 Million ≈ $33.11 Million	0.168x	-28.46%
2004-12-31	€107.97 Million ≈ $126.22 Million	€25.29 Million ≈ $29.57 Million	0.234x	+46.49%
2003-12-31	€103.29 Million ≈ $120.75 Million	€16.52 Million ≈ $19.31 Million	0.160x	+619.93%
2002-12-31	€110.79 Million ≈ $129.53 Million	€2.46 Million ≈ $2.88 Million	0.022x	--

About Biotest Aktiengesellschaft

XETRA:BIO3 Germany

Market Cap

$656.94 Million

€561.91 Million EUR

Market Cap Rank

#11037 Global

#1260 in Germany

Share Price

€28.40

Change (1 day)

+0.00%

52-Week Range

€28.40 - €28.40

All Time High

€43.69